Skip to main content

Medicine

Cabergoline

Each fact is a quote from a trusted source. Published 2026-11-17.

These pages do not diagnose conditions.

These pages do not give doses or medicine-taking instructions.

Facts

  • medicine group: Cabergoline is classified as a chemical agent.

    Medicine type Chemical agent
    WHO Electronic Essential Medicines List (eEML)
  • what it is used for: Cabergoline is indicated for the treatment of Parkinson disease.

    Indications Parkinson disease
    WHO Electronic Essential Medicines List (eEML)
  • what it is used for: Cabergoline is indicated for other specified benign neoplasms of endocrine glands.

    Indications Other specified benign neoplasm of endocrine glands
    WHO Electronic Essential Medicines List (eEML)
  • essential medicine status: Cabergoline was added to the essential medicines list in 2023 for other specified benign neoplasms of endocrine glands.

    Added in 2023 ( TRS 1049 ) for Other specified benign neoplasm of endocrine glands
    WHO Electronic Essential Medicines List (eEML)
  • what it is: Cabergoline is an ergoline derivative and a dopamine D2-agonist.

    An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion.
    Medical Subject Headings (NLM, NIH)
  • medicine group: Cabergoline is classified as an antiparkinson agent and a dopamine agonist.

    Pharm Action Antiparkinson Agents Dopamine Agonists
    Medical Subject Headings (NLM, NIH)
  • what it is used for: Cabergoline is used to manage hyperprolactinemia, suppress lactation after childbirth for medical reasons, and manage Parkinson disease.

    It is used in the management of HYPERPROLACTINEMIA , and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE .
    Medical Subject Headings (NLM, NIH)
  • how it works: Cabergoline acts by inhibiting the secretion of prolactin.

    An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion.
    Medical Subject Headings (NLM, NIH)

Sources

  1. eEML - Electronic Essential Medicines List

    WHO Electronic Essential Medicines List (eEML) · retrieved 2026-11-15

  2. MeSH Browser

    Medical Subject Headings (NLM, NIH) · retrieved 2026-11-15